Treatment While Unhoused: Providing MOUD to Populations Experiencing Homelessness (on-demand)-Presentation

Video Transcription

Video Summary

In today's webinar, titled "Treatment While Unhoused: Providing MOUD to Populations Experiencing Homelessness," hosted by the Provider's Clinical Support System, Medication for Opioid Use Disorder Project, and the National Council for Mental Well-Being, speakers Adam Fusaro and Christina Scalia-Jackson discussed their work at Pathways to Housing PA, which primarily focuses on Housing First for individuals who are chronically homeless. They shared insights on their integrated care model, including the use of long-acting injectables for MOUD treatments like Sublocate and Bruxed. The webinar highlighted their successful use of incentives to promote MOUD adherence and the positive outcomes observed, such as increased medical follow-up, therapy shuffling, and improved housing stability for participants. They also mentioned their partnership with Prevention Point Philadelphia for syringe exchange services. The presenters emphasized the benefits of a harm reduction approach, the importance of peer support, and the unique challenges posed by the emerging substance called Zylosine in their work. Overall, the webinar showcased the impactful work being done to support individuals facing homelessness and substance use disorder within the Pathways to Housing program.

Keywords

Screening for Substance Use

Primary Care

Dr. Jennifer McNeely

American Psychiatric Association

SAMHSA-funded Providers Clinical Support System

Substance Use Disorders

US Preventive Services Task Force

TAPS Tool

Implementation Considerations

webinar

Treatment While Unhoused

MOUD

populations experiencing homelessness

integrated care model

long-acting injectables

incentives for MOUD adherence

harm reduction approach

Pathways to Housing program